TRAJENTA 5MG TAB’S 30’S

Trajenta (linagliptin) is an oral medication used primarily for the management of type 2 diabetes mellitus. It belongs to a class of drugs known as DPP-4 inhibitors, which work by increasing the levels of incretin hormones. These hormones help to regulate blood sugar levels by stimulating insulin release from the pancreas and decreasing glucagon secretion, leading to lower blood glucose levels after meals.

Trajenta is typically prescribed for adults who need better glycemic control alongside diet and exercise. It can be used alone or in combination with other antidiabetic medications, such as metformin or sulfonylureas. The 5 mg tablet formulation is convenient for daily dosing, and it is generally well-tolerated with a low risk of causing hypoglycemia. Additionally, Trajenta may have cardiovascular benefits, making it a suitable option for patients with type 2 diabetes at risk for heart disease.